Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (181-190 of 240) with videos related to

Pageof 24
Sort By:
European Journal of Cancer & Clinical Oncology|June 1, 1985
Phase II trial of bleomycin in patients with advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group StudyJ B Vermorken, J P Armand, A J Lacave, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of CancerP Hurteloup, J P Armand, M Schneider, et al.
Cancer|October 15, 1990
Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycinH Sadek, N Azli, J L Wendling, et al.
The Laryngoscope|May 1, 1991
Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapyG Recondo, J P Armand, E Tellez-Bernal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility studyY Merrouche, J M Extra, D Abigerges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 1998
Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatinM Ducreux, P Rougier, A Fandi, et al.
Head & Neck|March 1, 1993
Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynxR Mahjoubi, M Bachouchi, J N Munck, et al.
American Journal of Clinical Oncology|August 1, 1996
Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinomaBensmaine M el-A, T Guillot, E T Bernal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinomaG Rousselet, M Bachouchi, P Busson, et al.
American Journal of Otolaryngology|September 1, 1993
Salvage chemotherapy in recurrent head and neck cancer: the Institut Gustave Roussy experienceJ P Armand, E Cvitkovic, G Recondo, et al.
Pageof 24

Showing results (181-190 of 240) with videos related to

Sort By:
Pageof 24
European Journal of Cancer & Clinical Oncology|June 1, 1985
Phase II trial of bleomycin in patients with advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group StudyJ B Vermorken, J P Armand, A J Lacave, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of CancerP Hurteloup, J P Armand, M Schneider, et al.
Cancer|October 15, 1990
Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycinH Sadek, N Azli, J L Wendling, et al.
The Laryngoscope|May 1, 1991
Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapyG Recondo, J P Armand, E Tellez-Bernal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility studyY Merrouche, J M Extra, D Abigerges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 1998
Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatinM Ducreux, P Rougier, A Fandi, et al.
Head & Neck|March 1, 1993
Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynxR Mahjoubi, M Bachouchi, J N Munck, et al.
American Journal of Clinical Oncology|August 1, 1996
Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinomaBensmaine M el-A, T Guillot, E T Bernal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinomaG Rousselet, M Bachouchi, P Busson, et al.
American Journal of Otolaryngology|September 1, 1993
Salvage chemotherapy in recurrent head and neck cancer: the Institut Gustave Roussy experienceJ P Armand, E Cvitkovic, G Recondo, et al.
Pageof 24